Ocata Therapeutics Inc

(OCAT) Trade

By |

Profile

Ocata Therapeutics Inc is a clinical stage biotechnology company in development & commercialization of Regenerative Ophthalmology therapeutics for Stargardt's macular degeneration, dry age-related macular degeneration, & myopic macular degeneration.

Contact Information

Website: www.ocata.com
Main Phone: +1 508 756-1212
Address: 33 Locke Drive
State: MA
City / Town: Marlborough
Country: USA
Postal Code: 01752

Issuer Information

Exchange: NSD
CEO: Paul K. Wotton
Employees: 37
NAICS: Pharmaceutical Preparation Manufacturing (325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 8.71 52 Wk Low 3.06
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 42,300,462.00 EPS (TTM) -0.67 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Robert P. Lanza 1,000
Robert P. Lanza 1,000
Robert P. Lanza 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8.5 8.5 8.5 8.5
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 8.25 8.25 8.25 8.25
Standard Deviation 0.35 0.35 0.35 0.35
Date of Most Recent Estimate 11/24/15 11/24/15 11/24/15 11/24/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 3 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.33 2.33 2.5 2.33